ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 52 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $22,000 | -33.3% | 10,339 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $33,000 | -15.4% | 10,339 | -30.3% | 0.00% | 0.0% |
| Q4 2016 | $39,000 | -32.8% | 14,839 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $58,000 | +3.6% | 14,839 | -28.8% | 0.00% | -25.0% |
| Q2 2016 | $56,000 | -12.5% | 20,839 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $64,000 | -17.9% | 20,839 | -18.9% | 0.00% | 0.0% |
| Q3 2015 | $78,000 | -28.4% | 25,709 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $109,000 | +10.1% | 25,709 | 0.0% | 0.00% | +33.3% |
| Q1 2015 | $99,000 | -42.8% | 25,709 | 0.0% | 0.00% | -50.0% |
| Q4 2014 | $173,000 | +22.7% | 25,709 | 0.0% | 0.01% | +50.0% |
| Q3 2014 | $141,000 | -46.6% | 25,709 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $264,000 | -14.6% | 25,709 | 0.0% | 0.01% | -11.1% |
| Q1 2014 | $309,000 | -46.2% | 25,709 | -49.3% | 0.01% | -50.0% |
| Q4 2013 | $574,000 | +68.3% | 50,709 | 0.0% | 0.02% | +63.6% |
| Q3 2013 | $341,000 | -27.4% | 50,709 | 0.0% | 0.01% | -38.9% |
| Q2 2013 | $470,000 | – | 50,709 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |